Unity Biotechnology, Inc.
UBX · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $17,546 | $16,430 | $24,768 | $22,364 |
| - Cash | $7,999 | $7,580 | $8,898 | $7,584 |
| + Debt | $22,607 | $23,539 | $20,698 | $21,659 |
| Enterprise Value | $32,154 | $32,389 | $36,568 | $36,439 |
| Revenue | $0 | $1,328 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$178 | $664 | -$216 | -$221 |
| % Margin | – | 50% | – | – |
| EBITDA | -$6,713 | -$8,237 | -$6,265 | -$5,058 |
| % Margin | – | -620.3% | – | – |
| Net Income | -$7,302 | -$8,440 | -$6,481 | -$5,279 |
| % Margin | – | -635.5% | – | – |
| EPS Diluted | -0.43 | -0.5 | -0.38 | -0.31 |
| % Growth | 14% | -31.6% | -22.6% | – |
| Operating Cash Flow | -$6,357 | -$5,905 | -$5,193 | -$4,584 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6,357 | -$5,905 | -$5,193 | -$4,584 |